Hubei Biocause Heilen Pharmaceutical Co., Ltd.

Equities

301211

CNE100005782

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
16.4 CNY +0.18% Intraday chart for Hubei Biocause Heilen Pharmaceutical Co., Ltd. -4.15% -24.60%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Chart Hubei Biocause Heilen Pharmaceutical Co., Ltd.
More charts
Hubei Biocause Heilen Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of chemical Active Pharmaceutical Ingredients (API) and preparation products. The Company's products can be divided into non-steroidal anti-inflammatory, cardiovascular and anti-tumor. The API products include Ibuprofen, D-Ibuprofen, Torasemide, Milrinone, Abiraterone Acetate, Granisetron Hydrochloride, Fludarabine Phosphate and others. The preparation products include Ibuprofen Granules, Ibuprofen Tablets, Ibuprofen Pseudoephedrine Tablets, Oxaprozin Enteric Coated Tablets, Oxaprozin Enteric Coated Capsules, Torasemide Tablets and others. The Company's products are exported to India, the United States, the European Union, South Korea and other countries.
More about the company
  1. Stock Market
  2. Equities
  3. 301211 Stock
  4. News Hubei Biocause Heilen Pharmaceutical Co., Ltd.
  5. Biocause Heilen Pharmaceutical's Cardiovascular Drug Passes Chinese Drug Regulator's Evaluation